---
title: "INNOGEN-B: H shares included in the eligible securities list for the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/268895414.md"
description: "INNOGEN-B's H shares have been included in the list of eligible securities for the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, effective December 8, 2025. This move will allow qualified investors in mainland China to directly invest in the company's H shares through the Shanghai and Shenzhen stock exchanges, which is expected to expand the investor base, increase trading volume, enhance investment value, and improve the company's reputation in the capital market"
datetime: "2025-12-08T04:09:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268895414.md)
  - [en](https://longbridge.com/en/news/268895414.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268895414.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/268895414.md) | [繁體中文](https://longbridge.com/zh-HK/news/268895414.md)


# INNOGEN-B: H shares included in the eligible securities list for the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect

According to the announcement from the Hong Kong Stock Exchange and the Shenzhen Stock Exchange, INNOGEN-B (02591) announced that its H shares have been included in the list of eligible securities for the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, effective from December 8, 2025.

After being included in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect, qualified investors in mainland China can directly invest in H shares through the Shanghai Stock Exchange and Shenzhen Stock Exchange. The Board of Directors believes that inclusion in the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect will further expand the company's investor base and increase the trading liquidity of H shares, thereby enhancing the investment value of H shares and the company's reputation in the capital market

### Related Stocks

- [INNOGEN-B (02591.HK)](https://longbridge.com/en/quote/02591.HK.md)

## Related News & Research

- [Guangzhou Innogen Wins Approval to Start Trials on Pet Diabetes Drug Efsubaglutide Alfa](https://longbridge.com/en/news/274887236.md)
- [ZAWYA: Boursa Kuwait to launch bonds and sukuk platform following CMA decision](https://longbridge.com/en/news/281743535.md)
- [China Minsheng (OTCMKTS:CMAKY) Issues Quarterly Earnings Results](https://longbridge.com/en/news/281388711.md)
- [China's detentions of Panama-flagged vessels raise concerns, Rubio says](https://longbridge.com/en/news/281541796.md)
- [Aurobindo Pharma says Curateq Biologics announces positive phase 3 results for omalizumab biosimilar BP11](https://longbridge.com/en/news/281754328.md)